Result of AGM

RNS Number : 8788S

Immupharma PLC

28 June 2018

 

                                                                                                                       28 JUNE 2018

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

2018 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.

-Ends-

For further information please contact: ImmuPharma PLC (www.immupharma.co.uk) + 44 (0) 20 7152 4080 Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations Twitter: @immupharma + 44 (0) 7721 413496 Northland Capital Partners Limited (NOMAD & Joint Broker) David Hignell, Dugald Carlean, Jamie Spotswood, Corporate Finance Rob Rees, Corporate Broking [phone] Bryan, Garnier & Co. (Joint Broker) Phil Walker, Corporate Finance Dominic Wilson, Sales [phone]

 

END

 

 

RAGFMGZVNRLGRZG